Amarin (NASDAQ: AMRN) reported second quarter 2020 results yesterday. During the earnings conference call, the management and the analysts discussed mainly the
Amarin (AMRN) Q2 2020 earnings call: Focus was mainly on VASCEPA litigation
Categories
Biotechnology
Immunogen Inc. (IMGN) Q2 2020 Earnings Call Transcript
Immunogen Inc (NASDAQ: IMGN) Q2 2020 earnings call dated July 31, 2020 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications and Investor
ImmunoGen (IMGN) Earnings: 2Q20 Key Numbers
ImmunoGen Inc. (NASDAQ: IMGN) reported second quarter 2020 earnings results today. Revenues were $15 million, compared to $15.5 million in the prior-year period. Net loss
Vertex Pharmaceuticals Inc. (VRTX) Q2 2020 Earnings Call Transcript
Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: Michael Partridge -- Senior Vice President, Investor Relations Reshma
Gilead Sciences Inc. (GILD) Q2 2020 Earnings Call Transcript
Gilead Sciences Inc (NASDAQ: GILD) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: Douglas Maffei -- Senior Director, Investor Relations Daniel O'Day -- Chairman
Infographic: Highlights from Gilead Sciences (GILD) Q2 2020 earnings
Gilead Sciences (NASDAQ: GILD) reported second-quarter financial results after the closing bell on Thursday. The biotechnology firm missed both the revenue and
Amgen Inc. (AMGN) Q2 2020 Earnings Call Transcript
Amgen Inc (NASDAQ: AMGN) Q2 2020 earnings call dated July 28, 2020 Corporate Participants: Arvind Sood -- Vice President of Investor Relations Robert A.
Biogen Inc. (BIIB) Q2 2020 Earnings Call Transcript
Biogen Inc. (NASDAQ: BIIB) Q2 2020 earnings call dated July 22, 2020 Corporate Participants: Joe Mara -- Vice President of Finance and Head of
Novartis International AG (NVS) Q2 2020 Earnings Call Transcript
Novartis International AG (NYSE: NVS) Q2 2020 earnings call dated Jul. 21, 2020 Corporate Participants: Samir Shah -- Global Head of Investor Relations Vasant
Infographic: Key financials of Biogen (BIIB) Q2 2020 earnings report
Biogen (NASDAQ: BIIB) reported a 12% increase in adjusted EPS and 2% growth in revenue for the second quarter of 2020. Adjusted
Moderna Inc (NASDAQ: MRNA) Moderna Vaccine Against COVID-19 Phase 1 Interim Results Publication Call Transcript
Moderna Inc (NASDAQ: MRNA) Moderna Vaccine Against COVID-19 Phase 1 Interim Results Publication Call dated July 15, 2020 Corporate Participants: Lavina Talukdar -- Head
Moderna medical chief: Varying infection rate to be the biggest challenge in Phase 3
A diverse population with varying infection rates will be among the biggest challenges during the phase 3 trials of its COVID-19 vaccine
Avid Bioservices, Inc. (NASDAQ: CDMO) Q4 2020 Earnings Call Transcript
Avid Bioservices, Inc. (CDMO) Q4 2020 earnings call dated June 30, 2020 Corporate Participants: Tim Brons -- Executive Vice President Rick Hancock -- Interim President and
Nektar Therapeutics (NASDAQ: NKTR) Q1 2020 Earnings Call Transcript
Nektar Therapeutics (NKTR) Q1 2020 earnings call dated May 07, 2020 Corporate Participants: Jennifer Ruddock -- Senior Vice President, Strategy and Corporate Affairs Howard
Amarin (AMRN) stock to remain within a tight range until the end of Vascepa litigation
The patent war between Amarin (NASDAQ: AMRN) and the generic companies for cardiovascular drug Vascepa continues to be a headwind for Amarin.
Affimed N.V. (NASDAQ: AFMD) Q1 2020 Earnings Call Transcript
Affimed N.V. (AFMD) Q1 2020 earnings call dated Jun. 23, 2020 Corporate Participants: Alexander Fudukidis -- Head of Investor Relations Adi Hoess -- Chief Executive Officer
Eli Lilly (LLY) appears to be on a strong footing with COVID-19 drug development efforts
Eli Lilly & Co.’s (NYSE: LLY) shares have gained 29% since the beginning of the year and 16% over the past three
FibroGen Inc (NASDAQ: FGEN) Q1 2020 Earnings Call Transcript
FibroGen Inc (FGEN) Q1 2020 earnings call dated May 08, 2020 Corporate Participants: Michael Tung -- Corporate Strategy Investor Relations Enrique Conterno -- Chief Executive Officer
Ionis Pharmaceuticals Inc. (NASDAQ: IONS) Q1 2020 Earnings Call Transcript
Ionis Pharmaceuticals Inc. (IONS) Q1 2020 earnings call dated May 06, 2020 Corporate Participants: Wade Walke, Ph.D. -- Vice President, Investor Relations Brett P.
Xenon Pharmaceuticals Inc (NASDAQ: XENE) Q1 2020 Earnings Call Transcript
Xenon Pharmaceuticals Inc (XENE) Q1 2020 earnings call dated May 21, 2020 Corporate Participants: Jodi Regts -- Vice President, Corporate Affairs and Investor Relations.
Karyopharm Therapeutics Inc (NASDAQ: KPTI) Q1 2020 Earnings Call Transcript
Karyopharm Therapeutics Inc (KPTI) Q1 2020 earnings call dated May 05, 2020 Corporate Participants: Ian Karp -- Vice President, Investor and Public Relations Michael